81 related articles for article (PubMed ID: 9791689)
21. Telomerase activity and Nm23-H2 protein expression in hepatocellular carcinoma.
Iizuka N; Mori N; Tamesa T; Tangoku A; Oka M
Anticancer Res; 2003; 23(1A):43-7. PubMed ID: 12680194
[TBL] [Abstract][Full Text] [Related]
22. DR-nm23 expression affects neuroblastoma cell differentiation, integrin expression, and adhesion characteristics.
Amendola R; Martinez R; Negroni A; Venturelli D; Tanno B; Calabretta B; Raschellà G
Med Pediatr Oncol; 2001 Jan; 36(1):93-6. PubMed ID: 11464913
[TBL] [Abstract][Full Text] [Related]
23. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
Cao LQ; Chen XM; Li X
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
[TBL] [Abstract][Full Text] [Related]
24. Nm23 and cathepsin D expression in laryngeal carcinomas.
Hadice Elif Pestereli ; Gulay Ozbilim ; Ozlem Elpek ; Firat Fisenk ; Esor Balkan
Adv Clin Path; 2000 Jul; 4(3):121-5. PubMed ID: 11080791
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2 expression inversely correlates with tumour cell differentiation in medulloblastoma.
Schüller U; Schober F; Kretzschmar HA; Herms J
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):513-21. PubMed ID: 15488027
[TBL] [Abstract][Full Text] [Related]
26. [Association of nm23-H1 with orthopedic oncological conditions].
Ha L; Guo W; Feng C; Li H
Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):477-9. PubMed ID: 11825445
[TBL] [Abstract][Full Text] [Related]
27. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
[TBL] [Abstract][Full Text] [Related]
28. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
[TBL] [Abstract][Full Text] [Related]
29. NM23 expression as prognostic factor in colorectal carcinoma.
Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
[TBL] [Abstract][Full Text] [Related]
30. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
31. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
32. Cerebellar desmoplastic medulloblastomas. A further immunohistochemical characterization of the reticulin-free pale islands.
Katsetos CD; Herman MM; Frankfurter A; Gass P; Collins VP; Walker CC; Rosemberg S; Barnard RO; Rubinstein LJ
Arch Pathol Lab Med; 1989 Sep; 113(9):1019-29. PubMed ID: 2505732
[TBL] [Abstract][Full Text] [Related]
33. Calbindin-d(28k): a marker of recurrence for medulloblastomas.
Pelc K; Vincent S; Ruchoux MM; Kiss R; Pochet R; Sariban E; Decaestecker C; Heizmann CW
Cancer; 2002 Jul; 95(2):410-9. PubMed ID: 12124842
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of classical vs. desmoplastic medulloblastomas.
Pramanik P; Sharma MC; Mukhopadhyay P; Singh VP; Sarkar C
Neurol India; 2003 Mar; 51(1):27-34. PubMed ID: 12865511
[TBL] [Abstract][Full Text] [Related]
35. [nm23 expression and its correlation with lung metastasis in human salivary adenoid cystic carcinoma].
Shi H; He R; Qiu W
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Jan; 32(1):4-6. PubMed ID: 10677933
[TBL] [Abstract][Full Text] [Related]
36. Lack of prognostic significance of nm23 expression in human primary breast cancer.
Göhring UJ; Eustermann I; Becker M; Neuhaus W; Rein DT; Schöndorf T
Oncol Rep; 2002; 9(6):1205-8. PubMed ID: 12375020
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
Krause FS; Feil G; Bichler KH
Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
[TBL] [Abstract][Full Text] [Related]
38. Survivin is a negative prognostic marker in medulloblastoma.
Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
[TBL] [Abstract][Full Text] [Related]
39. The role of nm23 in melanoma progression and its prognostic significance.
Betke H; Korabiowska M; Brinck U; Trybus-Gałuszka H; Kellner S; Okoń K; Stachura J; Droese M
Pol J Pathol; 1998; 49(2):93-6. PubMed ID: 9798412
[TBL] [Abstract][Full Text] [Related]
40. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].
Liu H; Mao H; Fu X
Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):224-7. PubMed ID: 11783092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
